-
Notifications
You must be signed in to change notification settings - Fork 1
/
nci_ids.json
209 lines (209 loc) · 16.6 KB
/
nci_ids.json
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
{
"ATR signaling pathway": "8991cbac-618b-11e5-8ac5-06603eb7f303",
"a4b7 Integrin signaling": "6e798e11-6186-11e5-8ac5-06603eb7f303",
"IL5-mediated signaling events": "e1d816a1-6193-11e5-8ac5-06603eb7f303",
"Canonical NF-kappaB pathway": "7a1a9c3c-618f-11e5-8ac5-06603eb7f303",
"E2F transcription factor network": "bb4d0fd3-6191-11e5-8ac5-06603eb7f303",
"p53 pathway": "a0de862d-6194-11e5-8ac5-06603eb7f303",
"Validated transcriptional targets of AP1 family members Fra1 and Fra2": "76d028a7-6196-11e5-8ac5-06603eb7f303",
"Beta5 beta6 beta7 and beta8 integrin cell surface interactions": "108637d6-618e-11e5-8ac5-06603eb7f303",
"Integrin family cell surface interactions": "1ca2bf67-6194-11e5-8ac5-06603eb7f303",
"Posttranslational regulation of adherens junction stability and dissassembly": "ebb21a59-6194-11e5-8ac5-06603eb7f303",
"S1P4 pathway": "821b0c12-6195-11e5-8ac5-06603eb7f303",
"Internalization of ErbB1": "3aa9aafa-6194-11e5-8ac5-06603eb7f303",
"PDGF receptor signaling network": "c5bcd922-6194-11e5-8ac5-06603eb7f303",
"RhoA signaling pathway": "5c6b5f5c-6195-11e5-8ac5-06603eb7f303",
"Class I PI3K signaling events mediated by Akt": "046a84e6-6191-11e5-8ac5-06603eb7f303",
"Aurora A signaling": "f131cf8e-618b-11e5-8ac5-06603eb7f303",
"Signaling events mediated by PRL": "bb67523a-6195-11e5-8ac5-06603eb7f303",
"S1P3 pathway": "7cb02d01-6195-11e5-8ac5-06603eb7f303",
"Visual signal transduction Rods": "962c6b0e-6196-11e5-8ac5-06603eb7f303",
"Endothelins": "dfb9dc47-6191-11e5-8ac5-06603eb7f303",
"Beta2 integrin cell surface interactions": "95b6b434-618d-11e5-8ac5-06603eb7f303",
"Integrins in angiogenesis": "2ddeac89-6194-11e5-8ac5-06603eb7f303",
"Ephrin A reverse signaling": "134e5bdb-6192-11e5-8ac5-06603eb7f303",
"FoxO family signaling": "d06dbbda-6192-11e5-8ac5-06603eb7f303",
"LPA receptor mediated events": "4b994cde-6194-11e5-8ac5-06603eb7f303",
"Alternative NF-kappaB pathway": "557add8c-6188-11e5-8ac5-06603eb7f303",
"E-cadherin signaling in the nascent adherens junction": "aef0d8c2-6191-11e5-8ac5-06603eb7f303",
"IL12-mediated signaling events": "7acdea19-6193-11e5-8ac5-06603eb7f303",
"IL6-mediated signaling events": "e684d5d2-6193-11e5-8ac5-06603eb7f303",
"Signaling events mediated by focal adhesion kinase": "8fb80085-6195-11e5-8ac5-06603eb7f303",
"Caspase Cascade in Apoptosis": "b9d3ef2e-618f-11e5-8ac5-06603eb7f303",
"Regulation of RhoA activity": "49ece019-6195-11e5-8ac5-06603eb7f303",
"EPHA2 forward signaling": "fb172ba9-6191-11e5-8ac5-06603eb7f303",
"Nectin adhesion pathway": "685baa82-6194-11e5-8ac5-06603eb7f303",
"Regulation of RAC1 activity": "351aacd6-6195-11e5-8ac5-06603eb7f303",
"Syndecan-4-mediated signaling events": "076bc549-6196-11e5-8ac5-06603eb7f303",
"VEGFR3 signaling in lymphatic endothelium": "9048d98c-6196-11e5-8ac5-06603eb7f303",
"Regulation of CDC42 activity": "0ffe6681-6195-11e5-8ac5-06603eb7f303",
"Validated nuclear estrogen receptor alpha network": "58949883-6196-11e5-8ac5-06603eb7f303",
"IL4-mediated signaling events": "cff33f50-6193-11e5-8ac5-06603eb7f303",
"Class I PI3K signaling events": "12b82bb7-6191-11e5-8ac5-06603eb7f303",
"Calcineurin-regulated NFAT-dependent transcription in lymphocytes": "0439e9da-618f-11e5-8ac5-06603eb7f303",
"Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling": "503076a2-6196-11e5-8ac5-06603eb7f303",
"ErbB receptor signaling network": "2c26d51f-6192-11e5-8ac5-06603eb7f303",
"Regulation of nuclear SMAD23 signaling": "246aac04-6195-11e5-8ac5-06603eb7f303",
"PLK1 signaling events": "e5e87977-6194-11e5-8ac5-06603eb7f303",
"PDGFR-beta signaling pathway": "c901a3e4-6194-11e5-8ac5-06603eb7f303",
"Validated nuclear estrogen receptor beta network": "5fb983a4-6196-11e5-8ac5-06603eb7f303",
"Stabilization and expansion of the E-cadherin adherens junction": "f1a6cd94-6195-11e5-8ac5-06603eb7f303",
"Fanconi anemia pathway": "6befb873-6192-11e5-8ac5-06603eb7f303",
"Presenilin action in Notch and Wnt signaling": "f51de83a-6194-11e5-8ac5-06603eb7f303",
"ErbB2ErbB3 signaling events": "51e35311-6192-11e5-8ac5-06603eb7f303",
"Sphingosine 1-phosphate (S1P) pathway": "eff796f3-6195-11e5-8ac5-06603eb7f303",
"Hedgehog signaling events mediated by Gli proteins": "153b6970-6193-11e5-8ac5-06603eb7f303",
"Signaling events mediated by PTP1B": "be498a9b-6195-11e5-8ac5-06603eb7f303",
"BARD1 signaling events": "75b04491-618c-11e5-8ac5-06603eb7f303",
"IL23-mediated signaling events": "b71d0ffd-6193-11e5-8ac5-06603eb7f303",
"Trk receptor signaling mediated by PI3K and PLC-gamma": "4037def0-6196-11e5-8ac5-06603eb7f303",
"CDC42 signaling events": "50b98ae0-6190-11e5-8ac5-06603eb7f303",
"IL1-mediated signaling events": "68fce8e7-6193-11e5-8ac5-06603eb7f303",
"Endogenous TLR signaling": "d8777e16-6191-11e5-8ac5-06603eb7f303",
"Signaling events mediated by VEGFR1 and VEGFR2": "d6f6ae1f-6195-11e5-8ac5-06603eb7f303",
"BCR signaling pathway": "acbf44e2-618c-11e5-8ac5-06603eb7f303",
"Regulation of p38-alpha and p38-beta": "3062ca15-6195-11e5-8ac5-06603eb7f303",
"Plexin-D1 Signaling": "e3068f36-6194-11e5-8ac5-06603eb7f303",
"Signaling events mediated by HDAC Class II": "a1da5607-6195-11e5-8ac5-06603eb7f303",
"a6b1 and a6b4 Integrin signaling": "73d1a893-6186-11e5-8ac5-06603eb7f303",
"Wnt signaling network": "987a2b9f-6196-11e5-8ac5-06603eb7f303",
"Arf6 downstream pathway": "1e972087-618a-11e5-8ac5-06603eb7f303",
"Insulin Pathway": "073b9f25-6194-11e5-8ac5-06603eb7f303",
"Signaling mediated by p38-gamma and p38-delta": "eef25bf2-6195-11e5-8ac5-06603eb7f303",
"LPA4-mediated signaling events": "53b0602f-6194-11e5-8ac5-06603eb7f303",
"Validated targets of C-MYC transcriptional repression": "6bbdafa6-6196-11e5-8ac5-06603eb7f303",
"ATF-2 transcription factor network": "c76c900a-618a-11e5-8ac5-06603eb7f303",
"Signaling events mediated by Stem cell factor receptor (c-Kit)": "c6b6861c-6195-11e5-8ac5-06603eb7f303",
"Alpha6 beta4 integrin-ligand interactions": "01416eb3-6188-11e5-8ac5-06603eb7f303",
"CXCR3-mediated signaling events": "3a38a0ca-6191-11e5-8ac5-06603eb7f303",
"Notch-mediated HESHEY network": "8ee56389-6194-11e5-8ac5-06603eb7f303",
"Calcium signaling in the CD4 TCR pathway": "5294f70b-618f-11e5-8ac5-06603eb7f303",
"Ephrin B reverse signaling": "149a63dc-6192-11e5-8ac5-06603eb7f303",
"PDGFR-alpha signaling pathway": "c66cc833-6194-11e5-8ac5-06603eb7f303",
"VEGFR1 specific signals": "8b13143b-6196-11e5-8ac5-06603eb7f303",
"IL12 signaling mediated by STAT4": "72cf19b8-6193-11e5-8ac5-06603eb7f303",
"ALK1 signaling events": "fcc72679-6186-11e5-8ac5-06603eb7f303",
"S1P2 pathway": "7796a240-6195-11e5-8ac5-06603eb7f303",
"RXR and RAR heterodimerization with other nuclear receptor": "6ce0a11e-6195-11e5-8ac5-06603eb7f303",
"AP-1 transcription factor network": "3ce2f9c5-6189-11e5-8ac5-06603eb7f303",
"Regulation of nuclear beta catenin signaling and target gene transcription": "1590a3b3-6195-11e5-8ac5-06603eb7f303",
"FAS (CD95) signaling pathway": "79cc9c14-6192-11e5-8ac5-06603eb7f303",
"ErbB4 signaling events": "6104ebb2-6192-11e5-8ac5-06603eb7f303",
"Arf6 signaling events": "3b3d91b8-618a-11e5-8ac5-06603eb7f303",
"Reelin signaling pathway": "054f432f-6195-11e5-8ac5-06603eb7f303",
"Alpha-synuclein signaling": "588134bc-6187-11e5-8ac5-06603eb7f303",
"IFN-gamma pathway": "51b1ed75-6193-11e5-8ac5-06603eb7f303",
"Signaling events mediated by HDAC Class I": "97e84126-6195-11e5-8ac5-06603eb7f303",
"PLK3 signaling events": "eac8a4b8-6194-11e5-8ac5-06603eb7f303",
"C-MYC pathway": "e3162de9-618e-11e5-8ac5-06603eb7f303",
"IL27-mediated signaling events": "c134fc5e-6193-11e5-8ac5-06603eb7f303",
"Regulation of Ras family activation": "397d91c7-6195-11e5-8ac5-06603eb7f303",
"Neurotrophic factor-mediated Trk receptor signaling": "774988f5-6194-11e5-8ac5-06603eb7f303",
"Validated transcriptional targets of TAp63 isoforms": "82e8ee19-6196-11e5-8ac5-06603eb7f303",
"IL8- and CXCR1-mediated signaling events": "f6a58ef3-6193-11e5-8ac5-06603eb7f303",
"mTOR signaling pathway": "559dd850-6194-11e5-8ac5-06603eb7f303",
"p75(NTR)-mediated signaling": "b492782f-6194-11e5-8ac5-06603eb7f303",
"Alpha4 beta1 integrin signaling events": "aa07df5d-6187-11e5-8ac5-06603eb7f303",
"Class IB PI3K non-lipid kinase events": "263703f8-6191-11e5-8ac5-06603eb7f303",
"Angiopoietin receptor Tie2-mediated signaling": "ad60647c-6188-11e5-8ac5-06603eb7f303",
"Signaling events mediated by HDAC Class III": "a7191c08-6195-11e5-8ac5-06603eb7f303",
"S1P5 pathway": "845321c3-6195-11e5-8ac5-06603eb7f303",
"p38 MAPK signaling pathway": "99bea41b-6194-11e5-8ac5-06603eb7f303",
"SHP2 signaling": "85755aa4-6195-11e5-8ac5-06603eb7f303",
"Ceramide signaling pathway": "d3747df2-6190-11e5-8ac5-06603eb7f303",
"Cellular roles of Anthrax toxin": "bb877621-6190-11e5-8ac5-06603eb7f303",
"Regulation of Telomerase": "4dfe97ca-6195-11e5-8ac5-06603eb7f303",
"IL2-mediated signaling events": "a2a1883c-6193-11e5-8ac5-06603eb7f303",
"Glucocorticoid receptor regulatory network": "dfba0dfb-6192-11e5-8ac5-06603eb7f303",
"Glypican 3 network": "07762c7e-6193-11e5-8ac5-06603eb7f303",
"PAR1-mediated thrombin signaling events": "be5084c0-6194-11e5-8ac5-06603eb7f303",
"Sumoylation by RanBP2 regulates transcriptional repression": "f70a59a5-6195-11e5-8ac5-06603eb7f303",
"BMP receptor signaling": "2a3c66e7-618e-11e5-8ac5-06603eb7f303",
"Glypican 2 network": "0723edcd-6193-11e5-8ac5-06603eb7f303",
"CD40CD40L signaling": "1971792f-6190-11e5-8ac5-06603eb7f303",
"Noncanonical Wnt signaling pathway": "7ff5fe76-6194-11e5-8ac5-06603eb7f303",
"p38 signaling mediated by MAPKAP kinases": "9d980dbc-6194-11e5-8ac5-06603eb7f303",
"Degradation of beta catenin": "61b6f2fc-6191-11e5-8ac5-06603eb7f303",
"IL2 signaling events mediated by STAT5": "9938526b-6193-11e5-8ac5-06603eb7f303",
"Role of Calcineurin-dependent NFAT signaling in lymphocytes": "61bdd46d-6195-11e5-8ac5-06603eb7f303",
"Circadian rhythm pathway": "ffb11b85-6190-11e5-8ac5-06603eb7f303",
"Ras signaling in the CD4 TCR pathway": "03079d1e-6195-11e5-8ac5-06603eb7f303",
"Signaling events mediated by the Hedgehog family": "d3a49cee-6195-11e5-8ac5-06603eb7f303",
"Syndecan-2-mediated signaling events": "fe05ead7-6195-11e5-8ac5-06603eb7f303",
"PAR4-mediated thrombin signaling events": "c3b87da1-6194-11e5-8ac5-06603eb7f303",
"Insulin-mediated glucose transport": "145e3376-6194-11e5-8ac5-06603eb7f303",
"HIF-2-alpha transcription factor network": "37358832-6193-11e5-8ac5-06603eb7f303",
"amb2 Integrin signaling": "5d4f90b6-6188-11e5-8ac5-06603eb7f303",
"ErbB1 downstream signaling": "30d60550-6192-11e5-8ac5-06603eb7f303",
"Beta1 integrin cell surface interactions": "2fd0bc63-618d-11e5-8ac5-06603eb7f303",
"p73 transcription factor network": "a88c505e-6194-11e5-8ac5-06603eb7f303",
"Beta3 integrin cell surface interactions": "c2800165-618d-11e5-8ac5-06603eb7f303",
"EPHA forward signaling": "f25420e8-6191-11e5-8ac5-06603eb7f303",
"Regulation of retinoblastoma protein": "407a3468-6195-11e5-8ac5-06603eb7f303",
"Nongenotropic Androgen signaling": "843e2f77-6194-11e5-8ac5-06603eb7f303",
"Direct p53 effectors": "67c3b75d-6191-11e5-8ac5-06603eb7f303",
"Arf6 trafficking events": "7a5b8f09-618a-11e5-8ac5-06603eb7f303",
"FOXA1 transcription factor network": "aa3927b7-6192-11e5-8ac5-06603eb7f303",
"HIV-1 Nef Negative effector of Fas and TNF-alpha": "41a75463-6193-11e5-8ac5-06603eb7f303",
"Plasma membrane estrogen receptor signaling": "dcc37895-6194-11e5-8ac5-06603eb7f303",
"Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)": "ac39d2b9-6195-11e5-8ac5-06603eb7f303",
"S1P1 pathway": "7327884f-6195-11e5-8ac5-06603eb7f303",
"Trk receptor signaling mediated by the MAPK pathway": "4980bb81-6196-11e5-8ac5-06603eb7f303",
"IL2 signaling events mediated by PI3K": "8bbf39aa-6193-11e5-8ac5-06603eb7f303",
"Netrin-mediated signaling events": "716a3d34-6194-11e5-8ac5-06603eb7f303",
"EGF receptor (ErbB1) signaling pathway": "a3139206-c718-11e6-86b1-0ac135e8bacf",
"Fc-epsilon receptor I signaling in mast cells": "86cd7795-6192-11e5-8ac5-06603eb7f303",
"Regulation of Androgen receptor activity": "094a8cb0-6195-11e5-8ac5-06603eb7f303",
"VEGF and VEGFR signaling network": "8957818a-6196-11e5-8ac5-06603eb7f303",
"C-MYB transcription factor network": "61020228-618e-11e5-8ac5-06603eb7f303",
"IL8- and CXCR2-mediated signaling events": "fe78e284-6193-11e5-8ac5-06603eb7f303",
"Alpha9 beta1 integrin signaling events": "0f5519cf-6188-11e5-8ac5-06603eb7f303",
"Syndecan-1-mediated signaling events": "f957cc16-6195-11e5-8ac5-06603eb7f303",
"N-cadherin signaling events": "5fc9c1e1-6194-11e5-8ac5-06603eb7f303",
"Validated targets of C-MYC transcriptional activation": "61d3b115-6196-11e5-8ac5-06603eb7f303",
"EPO signaling pathway": "20fe3c0e-6192-11e5-8ac5-06603eb7f303",
"Atypical NF-kappaB pathway": "d2dd121d-618b-11e5-8ac5-06603eb7f303",
"CXCR4-mediated signaling events": "46a5529b-6191-11e5-8ac5-06603eb7f303",
"Aurora C signaling": "72a32ba0-618c-11e5-8ac5-06603eb7f303",
"JNK signaling in the CD4 TCR pathway": "400ebdab-6194-11e5-8ac5-06603eb7f303",
"Visual signal transduction Cones": "9433a84d-6196-11e5-8ac5-06603eb7f303",
"HIF-1-alpha transcription factor network": "20ef2b81-6193-11e5-8ac5-06603eb7f303",
"Aurora B signaling": "304a75af-618c-11e5-8ac5-06603eb7f303",
"FOXA2 and FOXA3 transcription factor networks": "b6933be8-6192-11e5-8ac5-06603eb7f303",
"TRAIL signaling pathway": "3a79fddf-6196-11e5-8ac5-06603eb7f303",
"Rapid glucocorticoid signaling": "01db03fd-6195-11e5-8ac5-06603eb7f303",
"TNF receptor signaling pathway ": "316be05e-6196-11e5-8ac5-06603eb7f303",
"EPHB forward signaling": "01c81f4a-6192-11e5-8ac5-06603eb7f303",
"GMCSF-mediated signaling events": "095aa3ef-6193-11e5-8ac5-06603eb7f303",
"Integrin-linked kinase signaling": "21738158-6194-11e5-8ac5-06603eb7f303",
"DNA-PK pathway in nonhomologous end joining": "8dc10ede-6191-11e5-8ac5-06603eb7f303",
"FOXM1 transcription factor network": "c51cda49-6192-11e5-8ac5-06603eb7f303",
"EGFR-dependent Endothelin signaling events": "d4563605-6191-11e5-8ac5-06603eb7f303",
"Signaling events regulated by Ret tyrosine kinase": "e4431190-6195-11e5-8ac5-06603eb7f303",
"Syndecan-3-mediated signaling events": "052075b8-6196-11e5-8ac5-06603eb7f303",
"FGF signaling pathway": "98ed0df6-6192-11e5-8ac5-06603eb7f303",
"Osteopontin-mediated events": "94bf7f2a-6194-11e5-8ac5-06603eb7f303",
"Coregulation of Androgen receptor activity": "27e0e369-6191-11e5-8ac5-06603eb7f303",
"Signaling events mediated by TCPTP": "cd5ca44d-6195-11e5-8ac5-06603eb7f303",
"Regulation of cytoplasmic and nuclear SMAD23 signaling": "13312fe2-6195-11e5-8ac5-06603eb7f303",
"IGF1 pathway": "5e904cd6-6193-11e5-8ac5-06603eb7f303",
"RAC1 signaling pathway": "faffa4fc-6194-11e5-8ac5-06603eb7f303",
"NephrinNeph1 signaling in the kidney podocyte": "6cfb9873-6194-11e5-8ac5-06603eb7f303",
"Arf1 pathway": "faef51c6-6189-11e5-8ac5-06603eb7f303",
"ALK2 signaling events": "43d0451b-6187-11e5-8ac5-06603eb7f303",
"Retinoic acid receptors-mediated signaling": "5797691b-6195-11e5-8ac5-06603eb7f303",
"Effects of Botulinum toxin": "d236ff84-6191-11e5-8ac5-06603eb7f303",
"Notch signaling pathway": "88f83518-6194-11e5-8ac5-06603eb7f303",
"TGF-beta receptor signaling": "1f188fcc-6196-11e5-8ac5-06603eb7f303",
"IL3-mediated signaling events": "c868db9f-6193-11e5-8ac5-06603eb7f303",
"ATM pathway": "49bc3e2b-618b-11e5-8ac5-06603eb7f303",
"Canonical Wnt signaling pathway": "9dbe253d-618f-11e5-8ac5-06603eb7f303",
"Thromboxane A2 receptor signaling": "27d5800d-6196-11e5-8ac5-06603eb7f303",
"Hypoxic and oxygen homeostasis regulation of HIF-1-alpha": "4c0f3584-6193-11e5-8ac5-06603eb7f303",
"Glypican 1 network": "fb91e48c-6192-11e5-8ac5-06603eb7f303",
"E-cadherin signaling in keratinocytes": "a5f1af61-6191-11e5-8ac5-06603eb7f303",
"Lissencephaly gene (LIS1) in neuronal migration and development": "41fc83ec-6194-11e5-8ac5-06603eb7f303",
"Signaling mediated by p38-alpha and p38-beta": "e9dd8c21-6195-11e5-8ac5-06603eb7f303",
"Validated transcriptional targets of deltaNp63 isoforms": "7d7360a8-6196-11e5-8ac5-06603eb7f303",
"LKB1 signaling events": "4623bf6d-6194-11e5-8ac5-06603eb7f303"
}